{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T04:41:45Z","timestamp":1786250505924,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1245\/s10434-026-20013-8","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:03:54Z","timestamp":1781798634000},"page":"8175-8194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of Surgical Delay on Breast Cancer Prognosis: Systematic Review and Meta-analysis"],"prefix":"10.1245","volume":"33","author":[{"given":"Camille","family":"Gervais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Brouillette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Benzouak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin Katya","family":"Altuntur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipshita","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarkis","family":"Meterissian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"20013_CR1","doi-asserted-by":"publisher","unstructured":"Gradishar WJ, Moran MS, Abraham J, et al. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2024;22(5):331-57. https:\/\/doi.org\/10.6004\/jnccn.2024.0035","DOI":"10.6004\/jnccn.2024.0035"},{"key":"20013_CR2","doi-asserted-by":"publisher","first-page":"12091","DOI":"10.1038\/s41598-023-39259-3","volume":"13","author":"S Zhu","year":"2023","unstructured":"Zhu S, Li S, Huang J, Fei X, Shen K, Chen X. Time interval between breast cancer diagnosis and surgery is associated with disease outcome. Sci Rep. 2023;13:12091. https:\/\/doi.org\/10.1038\/s41598-023-39259-3.","journal-title":"Sci Rep."},{"issue":"10","key":"20013_CR3","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1245\/s10434-016-5486-7","volume":"23","author":"AC Polverini","year":"2016","unstructured":"Polverini AC, Nelson RA, Marcinkowski E, et al. Time to treatment: Measuring quality breast cancer care. Ann Surg Oncol. 2016;23(10):3392\u2013402. https:\/\/doi.org\/10.1245\/s10434-016-5486-7.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"20013_CR4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/jamaoncol.2015.4508","volume":"2","author":"RJ Bleicher","year":"2016","unstructured":"Bleicher RJ, Ruth K, Sigurdson ER, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2(3):330\u20139. https:\/\/doi.org\/10.1001\/jamaoncol.2015.4508.","journal-title":"JAMA Oncol"},{"issue":"5","key":"20013_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1001\/jamasurg.2022.8388","volume":"158","author":"AA Wiener","year":"2023","unstructured":"Wiener AA, Hanlon BM, Schumacher JR, Vande Walle KA, Wilke LG, Neuman HB. Reexamining time from breast cancer diagnosis to primary breast surgery. JAMA Surg. 2023;158(5):485\u201392. https:\/\/doi.org\/10.1001\/jamasurg.2022.8388.","journal-title":"JAMA Surg."},{"issue":"13","key":"20013_CR6","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.3390\/jcm13133966","volume":"13","author":"L Scardina","year":"2024","unstructured":"Scardina L, Carnassale B, Di Leone A, et al. Young women with early-stage breast cancer treated with upfront surgery: overview of oncological outcomes. J Clin Med. 2024;13(13):3966. https:\/\/doi.org\/10.3390\/jcm13133966.","journal-title":"J Clin Med."},{"key":"20013_CR7","doi-asserted-by":"publisher","unstructured":"Bleicher RJ, Hwang ES, Wilke LG, et al. Commission on cancer quality measures: Time to breast operation quality measure. J Am Coll Surg. 2023:https:\/\/doi.org\/10.1097\/XCS.0000000000001731.","DOI":"10.1097\/XCS.0000000000001731"},{"key":"20013_CR8","unstructured":"Quality Measures Program\u2014National Consortium of Breast Centers. Accessed April 11, 2026. https:\/\/www.nqmbc.org\/quality-measure-program\/quality-measures.cms"},{"key":"20013_CR9","unstructured":"Quality of Care Measures. ACS. Accessed April 11, 2026. https:\/\/www.facs.org\/quality-programs\/cancer-programs\/national-cancer-database\/quality-of-care-measures\/"},{"key":"20013_CR10","unstructured":"Quality measure for timeliness of care for breast cancer. Accessed April 11, 2026. https:\/\/www.breastsurgeons.org\/docs\/statements\/asbrs-qm-timeliness-of-care-for-breast-cancer.pdf"},{"issue":"11","key":"20013_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.110445","volume":"51","author":"T Reimer","year":"2025","unstructured":"Reimer T, Kuehn T, Mueller V, et al. AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025. Eur J Surg Oncol. 2025;51(11):110445. https:\/\/doi.org\/10.1016\/j.ejso.2025.110445.","journal-title":"Eur J Surg Oncol."},{"key":"20013_CR12","unstructured":"Newcastle-Ottawa Scale (NOS) | Ottawa Hospital Research Institute. Accessed April 11, 2026. https:\/\/ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale"},{"key":"20013_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. https:\/\/doi.org\/10.1136\/bmj.n160.","journal-title":"BMJ."},{"key":"20013_CR14","unstructured":"Covidence\u2014Better systematic review management. Covidence. 2025. Accessed July 10, 2024. https:\/\/www.covidence.org\/"},{"issue":"1","key":"20013_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12893-022-01835-1","volume":"22","author":"D An","year":"2022","unstructured":"An D, Choi J, Lee J, et al. Time to surgery and survival in breast cancer. BMC Surg. 2022;22(1):388. https:\/\/doi.org\/10.1186\/s12893-022-01835-1.","journal-title":"BMC Surg."},{"key":"20013_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.puhe.2023.09.011","volume":"225","author":"M Beaubrun-Renard","year":"2023","unstructured":"Beaubrun-Renard M, Ulric-Gervaise S, Veronique-Baudin J, et al. Breast cancer time to treatment in Martinique: predictive factors and effect on survival. Public Health. 2023;225:147\u201350. https:\/\/doi.org\/10.1016\/j.puhe.2023.09.011.","journal-title":"Public Health."},{"key":"20013_CR17","unstructured":"Deliere AE, Kuchta KM, Pesce CE, Kopkash KA, Yao KA. Impact of surgical delay on tumor upstaging and outcomes. J Am Coll Surg. Accessed May 23, 2025. https:\/\/journals.lww.com\/journalacs\/fulltext\/2022\/11000\/impact_of_surgical_delay_on_tumor_upstaging_and.15.aspx"},{"issue":"2","key":"20013_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10549-019-05404-8","volume":"178","author":"YL Eaglehouse","year":"2019","unstructured":"Eaglehouse YL, Georg MW, Shriver CD, Zhu K. Time-to-surgery and overall survival after breast cancer diagnosis in a universal health system. Breast Cancer Res Treat. 2019;178(2):441\u201350. https:\/\/doi.org\/10.1007\/s10549-019-05404-8.","journal-title":"Breast Cancer Res Treat."},{"issue":"5","key":"20013_CR19","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/ijc.31411","volume":"143","author":"L Eriksson","year":"2018","unstructured":"Eriksson L, Bergh J, Humphreys K, W\u00e4rnberg F, T\u00f6rnberg S, Czene K. Time from breast cancer diagnosis to therapeutic surgery and breast cancer prognosis: a population-based cohort study. Int J Cancer. 2018;143(5):1093\u2013104. https:\/\/doi.org\/10.1002\/ijc.31411.","journal-title":"Int J Cancer."},{"issue":"11","key":"20013_CR20","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.1245\/s10434-021-09747-9","volume":"28","author":"N Hills","year":"2021","unstructured":"Hills N, Leslie M, Davis R, et al. Prolonged time from diagnosis to breast-conserving surgery is associated with upstaging in hormone receptor-positive invasive ductal breast carcinoma. Ann Surg Oncol. 2021;28(11):5895\u2013905. https:\/\/doi.org\/10.1245\/s10434-021-09747-9.","journal-title":"Ann Surg Oncol."},{"key":"20013_CR21","doi-asserted-by":"publisher","unstructured":"Ho PJ, Cook AR, Binte Mohamed Ri NK, Liu J, Li J, Hartman M. Impact of delayed treatment in women diagnosed with breast cancer: A population-based study. Cancer Med. 2020;9(7):2435-44. https:\/\/doi.org\/10.1002\/cam4.2830","DOI":"10.1002\/cam4.2830"},{"issue":"4","key":"20013_CR22","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/jso.26332","volume":"123","author":"A Khader","year":"2021","unstructured":"Khader A, Chang SC, Santamaria-Barria J, et al. Delay in surgery is associated with axillary upstaging of clinically node negative breast cancer patients. J Surg Oncol. 2021;123(4):854\u201365. https:\/\/doi.org\/10.1002\/jso.26332.","journal-title":"J Surg Oncol."},{"key":"20013_CR23","doi-asserted-by":"publisher","unstructured":"Lee J, Jung JH, Kim WW, Park CS, Park HY. Patterns of delaying surgery for breast cancer during the COVID-19 outbreak in Daegu, South Korea. Front Surg. 2020. https:\/\/doi.org\/10.3389\/fsurg.2020.576196","DOI":"10.3389\/fsurg.2020.576196"},{"key":"20013_CR24","doi-asserted-by":"publisher","unstructured":"Leslie M, Pathak R, Dooley WC, et al. Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-Medicare. Res Square. Preprint posted online April 8, 2024. https:\/\/doi.org\/10.21203\/rs.3.rs-4171651\/v1","DOI":"10.21203\/rs.3.rs-4171651\/v1"},{"key":"20013_CR25","doi-asserted-by":"publisher","unstructured":"Luz FAC da, Marinho E da C, Nascimento CP, et al. The effect of delayed treatment in breast cancer patients: How much is too late? An experience of a single-center study effect of surgery delay in survival. Surg Oncol. 2022;44:101854. https:\/\/doi.org\/10.1016\/j.suronc.2022.101854","DOI":"10.1016\/j.suronc.2022.101854"},{"issue":"4","key":"20013_CR26","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/tbj.12758","volume":"23","author":"SA Mansfield","year":"2017","unstructured":"Mansfield SA, Abdel-Rasoul M, Terando AM, Agnese DM. Timing of breast cancer surgery: how much does it matter? Breast J. 2017;23(4):444\u201351. https:\/\/doi.org\/10.1111\/tbj.12758.","journal-title":"Breast J."},{"issue":"1","key":"20013_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/000313481808400124","volume":"84","author":"M Mariella","year":"2018","unstructured":"Mariella M, Kimbrough CW, Mcmasters KM, Ajkay N. Longer time intervals from diagnosis to surgical treatment in breast cancer: associated factors and survival impact. Am Surg. 2018;84(1):63\u201370. https:\/\/doi.org\/10.1177\/000313481808400124.","journal-title":"Am Surg."},{"issue":"5","key":"20013_CR28","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1245\/s10434-019-08050-y","volume":"27","author":"AM Mateo","year":"2020","unstructured":"Mateo AM, Mazor AM, Obeid E, et al. Time to surgery and the impact of delay in the non-neoadjuvant setting on triple negative breast cancers and other phenotypes. Ann Surg Oncol. 2020;27(5):1679\u201392. https:\/\/doi.org\/10.1245\/s10434-019-08050-y.","journal-title":"Ann Surg Oncol."},{"key":"20013_CR29","doi-asserted-by":"publisher","unstructured":"Minami CA, Kantor O, Weiss A, Nakhlis F, King TA, Mittendorf EA. Association between time to operation and pathologic stage in ductal carcinoma in situ and early-stage hormone receptor-positive breast cancer. J Am Coll Surg. 2020;231(4):434-47e2. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2020.06.021","DOI":"10.1016\/j.jamcollsurg.2020.06.021"},{"issue":"2","key":"20013_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10549-020-06012-7","volume":"186","author":"I Prakash","year":"2021","unstructured":"Prakash I, Thomas SM, Greenup RA, et al. Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer. Breast Cancer Res Treat. 2021;186(2):535\u201350. https:\/\/doi.org\/10.1007\/s10549-020-06012-7.","journal-title":"Breast Cancer Res Treat"},{"key":"20013_CR31","doi-asserted-by":"publisher","unstructured":"Reddy KP, Berkowitz CL, Jarrell K, et al. The effect of rurality on time to surgery and overall survival among women with breast cancer. Ann Surg. https:\/\/doi.org\/10.1097\/SLA.0000000000006710.","DOI":"10.1097\/SLA.0000000000006710"},{"issue":"6","key":"20013_CR32","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jamasurg.2013.1680","volume":"148","author":"EC Smith","year":"2013","unstructured":"Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race\/ethnicity. JAMA Surg. 2013;148(6):516\u201323. https:\/\/doi.org\/10.1001\/jamasurg.2013.1680.","journal-title":"JAMA Surg."},{"key":"20013_CR33","doi-asserted-by":"publisher","unstructured":"Tjoe JA, Heslin K, Thomas S, Kram JJF. Time from breast cancer diagnosis to surgery in a community health care system: Does time to surgery impact recurrence\/death? J Am Coll Surg. 2019;229(4, Supplement 2):e7. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2019.08.883","DOI":"10.1016\/j.jamcollsurg.2019.08.883"},{"issue":"2","key":"20013_CR34","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1245\/s10434-019-07844-4","volume":"27","author":"WH Ward","year":"2020","unstructured":"Ward WH, DeMora L, Handorf E, et al. Preoperative delays in the treatment of DCIS and the associated incidence of invasive breast cancer. Ann Surg Oncol. 2020;27(2):386\u201396. https:\/\/doi.org\/10.1245\/s10434-019-07844-4.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"20013_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00268-020-05725-6","volume":"44","author":"J Xu","year":"2020","unstructured":"Xu J, Bromley L, Chew G, Yeo B. \u201cFirst do no harm\u201d: Significance of delays from diagnosis to surgery in patients with non-metastatic breast cancer. World J Surg. 2020;44(11):1. https:\/\/doi.org\/10.1007\/s00268-020-05725-6.","journal-title":"World J Surg"},{"issue":"3","key":"20013_CR36","doi-asserted-by":"publisher","first-page":"962","DOI":"10.4143\/crt.2015.173","volume":"48","author":"TK Yoo","year":"2015","unstructured":"Yoo TK, Han W, Moon HG, et al. Delay of treatment initiation does not adversely affect survival outcome in breast cancer. Cancer Res Treat. 2015;48(3):962\u20139. https:\/\/doi.org\/10.4143\/crt.2015.173.","journal-title":"Cancer Res Treat."},{"issue":"2","key":"20013_CR37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1258\/jhsrp.2011.010113","volume":"17","author":"F Walter","year":"2012","unstructured":"Walter F, Webster A, Scott S, Emery J. The Andersen Model of Total Patient Delay: a systematic review of its application in cancer diagnosis. J Health Serv Res Policy. 2012;17(2):110\u20138. https:\/\/doi.org\/10.1258\/jhsrp.2011.010113.","journal-title":"J Health Serv Res Policy."},{"issue":"1","key":"20013_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/1472-6963-9-189","volume":"9","author":"RS Andersen","year":"2009","unstructured":"Andersen RS, Vedsted P, Olesen F, Bro F, S\u00f8ndergaard J. Patient delay in cancer studies: a discussion of methods and measures. BMC Health Serv Res. 2009;9(1):189. https:\/\/doi.org\/10.1186\/1472-6963-9-189.","journal-title":"BMC Health Serv Res."},{"issue":"6","key":"20013_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-061121","volume":"12","author":"KE Morrill","year":"2022","unstructured":"Morrill KE, Robles-Morales R, Lopez-Pentecost M, et al. Factors associated with cancer treatment delay: a protocol for a systematic review and meta-analysis. BMJ Open. 2022;12(6):e061121. https:\/\/doi.org\/10.1136\/bmjopen-2022-061121.","journal-title":"BMJ Open."},{"key":"20013_CR40","unstructured":"Wait times for priority procedures, 2019 to 2024: Insights into trends and contributing factors | CIHI. Accessed October 19, 2025. https:\/\/www.cihi.ca\/en\/wait-times-for-priority-procedures-2019-to-2024-insights-into-trends-and-contributing-factors"},{"issue":"13","key":"20013_CR41","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.20.03399","volume":"39","author":"LA Korde","year":"2021","unstructured":"Korde LA, Somerfield MR, Carey LA, et al. Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO Guideline. J Clin Oncol. 2021;39(13):1485\u2013505. https:\/\/doi.org\/10.1200\/JCO.20.03399.","journal-title":"J Clin Oncol."},{"issue":"12","key":"20013_CR42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1200\/OP.21.00635","volume":"17","author":"C Shah","year":"2021","unstructured":"Shah C, Al-Hilli Z, Vicini F. Advances in breast cancer radiotherapy: implications for current and future practice. JCO Oncol Pract. 2021;17(12):697\u2013706. https:\/\/doi.org\/10.1200\/OP.21.00635.","journal-title":"JCO Oncol Pract."},{"key":"20013_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2025.104454","volume":"81","author":"D Wang","year":"2025","unstructured":"Wang D, Sun X, Sun W, Wang R, Pan H, Zhou W. Influence of surgical timing post-neoadjuvant chemotherapy on survival outcomes in breast cancer patients: a comprehensive systematic review and meta-analysis. Breast. 2025;81:104454. https:\/\/doi.org\/10.1016\/j.breast.2025.104454.","journal-title":"Breast."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20013-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20013-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20013-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T04:01:30Z","timestamp":1786248090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20013-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["20013"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20013-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Stephanie Wong - Advisory Board: AstraZeneca; Honoraria: AZ, Merck, Novartis.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}